CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Zydus Pharmaceuticals (USA) Inc recalls chlorproMAZINE Hydrochloride…

Zydus Pharmaceuticals (USA) Inc recalls chlorproMAZINE Hydrochloride Tablets

Read the official FDA notice

Published
16 Apr 2025
Units affected
3144 bottles, pack size: 100's Count
Agency
FDA
Country
United States

The hazard

CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

chlorproMAZINE Hydrochloride Tablets, USP 10 mg, Rx Only, 100 Tablets bottles, Manufactured by: Zydus Lifesciences Ltd., Baddi, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1129-1

Brand / company
Zydus Pharmaceuticals (USA) Inc
Codes / lots
Lot #: Z400069, Exp.: 12/31/2025
Distribution
Nationwide within U.S - MS, AL, TN, VT, OH, ND, MN, WI, SC, AR, FL, IN, LA, NJ, AZ, TX, KY and PA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 16 Apr 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.